Publications


Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma

Sophia Gayle, Sean Landrette, Neil Beeharry, Chris Conrad, Marylens Hernandez, Paul Beckett, Shawn M. Ferguson, Talya Mandelkern, Meiling Zheng, Tian Xu, Jonathan Rothberg and Henri Lichenstein
Blood 2017 :blood-2016-09-736892; doi: https://doi.org/10.1182/blood-2016-09-736892

View publication (PDF, 0.6 MB)

View supplemental methods, figures, and data (PDF, 1.1 MB)